Daiichi Sankyo Company, Limited (DSNKY)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 10:19AM EDT. Market open.
| Previous close | 30.86 |
| Open | 31.96 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 31.84 - 32.23 |
| 52-week range | 23.72 - 37.57 |
| Volume | |
| Avg. volume | 144,733 |
| Market cap | 61.801B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 47.40 |
| EPS (TTM) | 0.68 |
| Earnings date | N/A |
| Forward dividend & yield | 0.24 (0.79%) |
| Ex-dividend date | 28 Sept 2023 |
| 1y target est | N/A |
Yahoo FinanceAstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain'
AstraZeneca CEO Pascal Soriot joined Yahoo Finance to discuss the company's earnings today.
ZacksAtossa (ATOS) Reports Positive Results From EVANGELINE Study
Atossa (ATOS) unveils positive results from its phase 2 EVANGELINE clinical study, which shows that (Z)-endoxifen can reduce the growth of ER+ breast cancer.
ZacksMerck (MRK) Begins Phase II/II Ovarian Cancer Study on ADC Drug (Revised)
Merck's (MRK) phase II/III study called REJOICE-Ovarian01 study will evaluate the efficacy of raludotatug deruxtecan in patients with platinum-resistant ovarian cancer.
© 2024 Yahoo. All rights reserved.